Powered by Google TranslateTranslate
Original text
Rate this translation
Your feedback will be used to help improve Google Translate
Latest Press Releases
View all
TimeHeadline
9h agoDelivery Hero confirms approach by Uber Technologies’ with respect to potential takeover offer
10h agoRefers to Item 7 on the agenda: Report on the audit of the consolidated financial statements of Grupa Kęty SA
12h agoThe 4th BOCHK Science and Technology Innovation Prize Award Ceremony Concludes with Great Success
19h agoBuffalo Potash Files Annual Information Form and New Technical Report
20h agoIonik Announces 30-Day Extension of Senior Debt Facility
Sight Sciences, Inc. logo

Sight Sciences, Inc.

About

5.03USD-0.11 -2.14%
Closed • Updated at 23:16 GMT+00:00
Market Cap$273.68M
Volume150.6K
Beta3.13
RSI57.62
Gross Margin86.17%
Health TechnologyMedical Specialties

Sight Sciences, Inc. — investor relations, events, news, and company updates on 6ix.

Latest News

May 6 2026
Sight Sciences Reports First Quarter 2026 Financial Results and Raises Full Year 2026 Revenue Guidance
Apr 21 2026
Sight Sciences to Report First Quarter 2026 Financial Results on May 6, 2026
Apr 1 2026
Sight Sciences’ Interventional Technologies for Glaucoma and Dry Eye Disease to be Featured in Multiple Clinical Presentations at the 2026 American Society of Cataract and Refractive Surgery (ASCRS) Annual Meeting
Mar 30 2026
Sight Sciences to Present at the 25th Annual Needham Healthcare Conference on April 13th
Mar 30 2026
Sight Sciences Secures Order on Post-Trial Motions That Preserves the Jury’s Verdict and Awards Monetary Damages to Sight Sciences Against Alcon and its Hydrus® Microstent

Community Chat

Ask AI

Try asking
6ix6ix